These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 26138744)
41. Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue. Park IH; Kwon Y; Ro JY; Lee KS; Ro J Breast Cancer Res Treat; 2010 Aug; 123(1):125-8. PubMed ID: 19916047 [TBL] [Abstract][Full Text] [Related]
42. A Pilot Study Evaluating Fine-Needle Aspiration Cytology of Clear-Cell Renal Cell Carcinoma: Comparison of Ancillary Immunocytochemistry and Cytomorphological Characteristics of SurePath™ Liquid-Based Preparations with Conventional Smears. Lee CH; Chung SY; Moon KC; Park IA; Chung YR; Ryu HS Acta Cytol; 2015; 59(3):239-47. PubMed ID: 26044824 [TBL] [Abstract][Full Text] [Related]
43. The role of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience. Rossi ED; Straccia P; Martini M; Revelli L; Lombardi CP; Pontecorvi A; Fadda G Cancer Cytopathol; 2014 May; 122(5):359-67. PubMed ID: 24474727 [TBL] [Abstract][Full Text] [Related]
44. Immunocytochemistry as an adjunct to diagnostic cytology. Dupré MP; Courtade-Saidi M Ann Pathol; 2012 Dec; 32(6):e47-51, 433-7. PubMed ID: 23244485 [TBL] [Abstract][Full Text] [Related]
45. Overview of nongynecological samples prepared with liquid-based cytology medium. Ren S; Solomides C; Draganova-Tacheva R; Bibbo M Acta Cytol; 2014; 58(6):522-32. PubMed ID: 25115150 [TBL] [Abstract][Full Text] [Related]
46. A randomized trial comparing conventional cytology to liquid-based cytology and computer assistance. Klug SJ; Neis KJ; Harlfinger W; Malter A; König J; Spieth S; Brinkmann-Smetanay F; Kommoss F; Weyer V; Ikenberg H Int J Cancer; 2013 Jun; 132(12):2849-57. PubMed ID: 23175270 [TBL] [Abstract][Full Text] [Related]
47. Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study. Monsonego J; Hudgens MG; Zerat L; Zerat JC; Syrjänen K; Halfon P; Ruiz F; Smith JS Int J Cancer; 2011 Aug; 129(3):691-701. PubMed ID: 20941740 [TBL] [Abstract][Full Text] [Related]
48. The implementation of liquid-based cytology for lung and pleural-based diseases. Michael CW; Bedrossian CC Acta Cytol; 2014; 58(6):563-73. PubMed ID: 25427721 [TBL] [Abstract][Full Text] [Related]
49. Multinational study of oestrogen and progesterone receptor immunocytochemistry on breast carcinoma fine needle aspirates. Marinšek ZP; Nolde N; Kardum-Skelin I; Nizzoli R; Onal B; Rezanko T; Tani E; Ostović KT; Vielh P; Schmitt F; Kocjan G Cytopathology; 2013 Feb; 24(1):7-20. PubMed ID: 23082931 [TBL] [Abstract][Full Text] [Related]
51. The application of immunocytochemistry to direct smears in the diagnosis of effusions. Knoepp SM; Placido J; Fields KL; Thomas D; Roh MH Diagn Cytopathol; 2013 May; 41(5):425-30. PubMed ID: 22549950 [TBL] [Abstract][Full Text] [Related]
52. ER, PR, and Her2 immunocytochemistry on cell-transferred cytologic smears of primary and metastatic breast carcinomas: a comparison study with formalin-fixed cell blocks and surgical biopsies. Ferguson J; Chamberlain P; Cramer HM; Wu HH Diagn Cytopathol; 2013 Jul; 41(7):575-81. PubMed ID: 22807465 [TBL] [Abstract][Full Text] [Related]
54. Precursor T-lymphoblastic lymphoma: Speedy diagnosis in FNA and effusion cytology by morphology, immunochemistry, and flow cytometry. Bhaker P; Das A; Rajwanshi A; Gautam U; Trehan A; Bansal D; Varma N; Srinivasan R Cancer Cytopathol; 2015 Sep; 123(9):557-65. PubMed ID: 26243719 [TBL] [Abstract][Full Text] [Related]
55. Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration. Fetsch PA; Powers CN; Zakowski MF; Abati A Cancer; 1999 Jun; 87(3):168-72. PubMed ID: 10385449 [TBL] [Abstract][Full Text] [Related]
56. Proposed Sheffield quantitative criteria in cervical cytology to assist the diagnosis and grading of squamous intra-epithelial lesions, as some Bethesda system definitions require amendment. Slater DN; Rice S; Stewart R; Melling SE; Hewer EM; Smith JH Cytopathology; 2005 Aug; 16(4):168-78. PubMed ID: 16048503 [TBL] [Abstract][Full Text] [Related]
57. Subclassification of non-small cell lung cancer by cytologic sampling: a logical approach with selective use of immunocytochemistry. Kimbrell HZ; Gustafson KS; Huang M; Ehya H Acta Cytol; 2012; 56(4):419-24. PubMed ID: 22846197 [TBL] [Abstract][Full Text] [Related]
58. Optimizing methods in immunocytochemistry: one laboratory's experience. Valli V; Peters E; Williams C; Shipp L; Barger A; Chladny J; Hoffmann W Vet Clin Pathol; 2009 Jun; 38(2):261-9. PubMed ID: 19351343 [TBL] [Abstract][Full Text] [Related]
59. A comprehensive antibody panel for immunohistochemical analysis of formalin-fixed, paraffin-embedded hematopoietic neoplasms of mice: analysis of mouse specific and human antibodies cross-reactive with murine tissue. Kunder S; Calzada-Wack J; Hölzlwimmer G; Müller J; Kloss C; Howat W; Schmidt J; Höfler H; Warren M; Quintanilla-Martinez L Toxicol Pathol; 2007 Apr; 35(3):366-75. PubMed ID: 17455084 [TBL] [Abstract][Full Text] [Related]
60. Liquid-based cytology of the breast: pitfalls unrecognized before specific liquid-based cytology training - proposal for a modification of the diagnostic criteria. Feoli F; Ameye L; Van Eeckhout P; Paesmans M; Marra V; Arisio R Acta Cytol; 2013; 57(4):369-76. PubMed ID: 23860126 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]